Загрузка...
Apatinib for molecular targeted therapy in tumor
As tumor angiogenesis is one of the hallmarks of cancer, the inhibition of vascular endothelial growth factor signaling has become an attractive anticancer approach. Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor-2, has demonstrated encouraging anticancer activit...
Сохранить в:
| Опубликовано в: : | Drug Des Devel Ther |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654530/ https://ncbi.nlm.nih.gov/pubmed/26622168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S97235 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|